Drug intelligence / Profile preview

Chitogel CSK-4

Development stage: Unknown
Lead developer: Chitogel
Modality: Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Chitogel CSK-4 is a biomaterial-based medical device composed of chitosan succinamide, a modified form of chitosan derived from crustacean chitin. It is designed as a hydrogel middle ear packing material for use during tympanoplasty surgery to repair tympanic membrane perforations. Developed and evaluated by the Henry Ford Health System, the material serves as a support structure, hemostatic agent, and wound-healing promoter. It aims to reduce acute inflammation and long-term fibrosis compared to traditional materials like Gelfoam. The hydrogel works by providing a physical scaffold that prevents scarring and promotes mucosal healing in the middle ear and external canal.

Brand names: Chitogel CSK-4Chitogel
Other names: chitosan succinamide

Beyond the preview

Go deeper on Chitogel CSK-4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chitogel CSK-4.

Explore the full profile